Curcumin therapy also leads to a modest amelioration of the phenotype in msd and PLP1 transgenic mouse models of PMD (Yu et al., 2012; Epplen et al., 2015), although the molecular mechanisms underlying curcumin action are still largely unknown. Here, PLP1 is linked to Pelizeaus-Merzbacher spectrum disorder.